1. Home
  2. BHC

as 10-07-2025 3:29pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: QUEBEC
Market Cap: 2.4B IPO Year: N/A
Target Price: $9.00 AVG Volume (30 days): 1.7M
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.27 EPS Growth: N/A
52 Week Low/High: $4.25 - $9.85 Next Earning Date: 10-29-2025
Revenue: $9,858,000,000 Revenue Growth: 7.13%
Revenue Growth (this year): 6.28% Revenue Growth (next year): 3.76%

Stock Insider Trading Activity of Bausch Health Companies Inc. (BHC)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Carson Seana BHC EVP, General Counsel Sep 8 '25 Sell $7.31 13,370 $97,734.70 499,585
Lee Frank D. BHC N/A Aug 21 '25 Sell $7.66 15,912 $121,885.92 73,795
Paulson John BHC N/A Aug 14 '25 Buy $9.00 34,721,118 $312,490,062.00 70,755,869
Paulson John BHC N/A Aug 13 '25 Buy $7.06 86,409 $610,047.54 70,755,869
Paulson John BHC N/A Aug 12 '25 Buy $6.88 1,156,640 $7,957,683.20 70,755,869
Paulson John BHC N/A Aug 11 '25 Buy $6.35 2,000,000 $12,700,000.00 70,755,869

Share on Social Networks: